Vanguard Personalized Indexing Management
STLN

Vanguard Personalized Indexing Management’s Starling Oncology STLN Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,984
Closed -$8.27K – 1816
2024
Q2 		$8.27K Sell
17,984
-975
-5% -$832 ﹤0.01% 1689
2024
Q1 		$30K Sell
18,959
-1,722
-8% -$3.27K ﹤0.01% 1593
2023
Q4 		$42.2K Sell
20,681
-588
-3% -$1.02K ﹤0.01% 1523
2023
Q3 		$29.8K Buy
+21,269
New +$22K ﹤0.01% 1434

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TAS
TIFF Advisory Services Radnor, Pennsylvania $408M AUM 20.34% 1-Year Est. Return
CI
Cincinnati Insurance Fairfield, Ohio $6.94B AUM 20.24% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Vanguard Personalized Indexing Management's STLN Position: Q3 2024 in Review

Vanguard Personalized Indexing Management sold out of Starling Oncology (STLN) in Q3 2024, closing a stake of 17,984 shares — an estimated $8.27K sold.

Vanguard Personalized Indexing Management first reported a position in STLN in Q3 2023 and held it in 4 quarters. The position peaked at $42.2K in Q4 2023. 34 funds tracked by Wall St. Rank hold STLN as of Q3 2024.

  • Vanguard Personalized Indexing Management reported no remaining Starling Oncology position as of Q3 2024 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 17,984 Starling Oncology shares in Q3 2024, an estimated $8.27K.
  • Vanguard Personalized Indexing Management first reported a position in Starling Oncology in Q3 2023 and held it in 4 quarters.
  • Vanguard Personalized Indexing Management's Starling Oncology position peaked at $42.2K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2024, filed 12 Nov 2024.